Germany – Hydrogen – Auction Procedure for the Purchase of Ammonia, Methanol or Hydrogen - North American Lot (NAL)

Environmental Protection · Germany government procurement

Closed July 04, 2025. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

Hintco strictly adheres to the principles of non-discrimination and transparency in order to ensure a high level of competition during the auction. The auction procedure is designed to be product-neutral. Producers can therefore supply renewable hydrogen or renewable ammonia or renewable methanol to Hintco. Hintco requires that the product is produced using renewable energy and in compliance with sustainability requirements as specified in the Performance Specifications and the Hydrogen Purchase Agreement, incl. its Annexes. The auction process will be carried out as follows: === First of all, Hintco will assess the eligibility of the candidates with regard to the subject of the auction. Interested companies must therefore submit a request to participate. === This request to participate is assessed by Hintco in two stages: first for a complete submission on time and in the correct form, then for eligibility based on defined criteria. Candidates meeting all minimum requirements will be invited to a negotiation phase (see Section 4 Conditions of Participation ). === Hintco will then invite all candidates who have submitted an eligible request to participate to a nondiscriminatory negotiation process that will take place before the submission of a bid (see Section 2 Conditions of the Bidding Phase ). === All bidders receive the same draft HPA as the basis for negotiaion proposals. Negotiations aim to create a single set of HPA contract terms for each regional lot, allowing for competitive bids. All bidders receive the same draft HPA, but the grey-highlighted contract sections are generally excluded from negotiations (deemed non-negotiable). This limit is mainly due to regulation, state aid rules, and Hintco’s operational setup. Exceptions may be considered in justified cases. After negotiations end, bidders have at least 8 weeks to prepare and submit their bids. The dead-line for the submission of bids will not be before March 2026. === Only bids meeting all formal...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyEnvironmental Protection
CountryGermany
CategoryPharmaceuticals
CPV24111600
PublishedJuly 04, 2025
Procurement stageRequest for Proposal (RFP)
ClosedJuly 04, 2025
StatusClosed — no longer accepting responses
TranslationTranslated from Hungarian by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Browse Similar Open Opportunities in Germany

Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Thalidomid, ATC L04AX02 (OBG) für die Zeit 01.11.2024 - 31.10.2026
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Formoterol/Glycopyrronium/Budesonid (ATC-Code nach WHO: R03AL11)
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Guanfacin, ATC N06BA21
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.09.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for medicinal products containing the active ingredient iron carboxymaltose (ATC code: B03AC01).
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Risperidon (ATC-Code N05AX08) eingeschränkt auf die Darreichung Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension.
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit der Wirkstoffkombination Adapalen + Benzoylperoxid
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Peginterferon beta-1a, ATC L03AB13

See every Germany Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Pharmaceuticals intelligence report in your inbox

A personalized report on Germany Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.